Stock listing

Munich:6GJ Glaukos Corporation Aktie

German listing (Munich) of Glaukos Corporation · home listing NYSE:GKOS

Follow Glaukos Corporation into a list and get an email when it puts out news.

Home listing price · NYSE:GKOS

$164.84 USD -0.76 (-0.5%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:GKOS

Since Jul 6, 2026 +10.9% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$163.13 – $167.28 USDOct 16, 2026
Volume
1.03M sharesOct 16, 2026
Market value
$9.72B USDAt the close on Oct 16, 2026 · price × 58.98M shares outstanding
Glaukos Corporation logo
Ticker
Munich:6GJ
Asset type
Stock
Exchange
Munich
Currency
EUR

What changed lately

Calls

Upcoming

  • Glaukos (NYSE:GKOS) Q3 2026 Earnings Call

    Wed, Oct 28, 2026 · 4:30 PM ET

    Register

Replays

  • Glaukos (NYSE:GKOS) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 4:30 PM ET

    Watch Transcript

  • Glaukos (NYSE:GKOS) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 4:30 PM ET

    Watch Transcript

  • Glaukos (NYSE:GKOS) Q4 2025 Earnings Call

    Tue, Feb 17, 2026 · 4:00 PM ET

    Watch Transcript

Latest news

Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination with Cataract Surgery

Oct 9, 2026

Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Biologic for Retinal Diseases

Oct 8, 2026

Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus

Oct 7, 2026

Glaukos Announces Second Quarter 2026 Financial Results

Jul 29, 2026

Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt

Jul 27, 2026

Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29

Jul 8, 2026

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis

Jun 25, 2026

Glaukos Announces First Quarter 2026 Financial Results

Apr 29, 2026

Glaukos Announces the Release of its 2025 Sustainability Report

Apr 16, 2026

Glaukos Receives Permanent J-code for Epioxa™

Apr 15, 2026

All Glaukos Corporation news

Decks

Glaukos Corporation on 6ix

News releases
25 in the last 12 months · 40 in all · newest Oct 9, 2026 · oldest 2025
Calls
26 calls with a replay · 26 with a transcript · latest Jul 29, 2026
Decks
65 decks · latest Aug 3, 2026

Where Glaukos Corporation is listed

ListingExchangeCountryCurrency
NYSE:GKOS · Home listingNYSEUnited StatesUSD
gettex:6GJgettexGermanyEUR
LS Exchange:A14VCKLS ExchangeGermanyEUR
Lang & Schwarz:A14VCKLang & SchwarzGermanyEUR
BX Swiss:GKOSBX SwissSwitzerlandCHF
BOATS:GKOSBOATSUnited StatesUSD
Dusseldorf:6GJDusseldorfGermanyEUR
Frankfurt:6GJFrankfurtGermanyEUR
Munich:6GJ · This pageMunichGermanyEUR
Stuttgart:6GJStuttgartGermanyEUR
Tradegate:6GJTradegateGermanyEUR
Xetra:6GJXetraGermanyEUR

Log in to ask 6ix AI your own questions about Glaukos Corporation.